Dermochondral corneal dystrophy is a rare familial disease initially described by Francois in 1949.12 It consists of a triad of abnormalities affecting the bones of the extremities, the skin, and the cornea. We describe previously unreported ocular manifestations in a pair of brothers whose dermatologic findings were previously investigated.3
FranVois) has been reported rarely in the literature. It consists of a triad of findings characterised by the development of skin nodules, acquired deformities of the extremities, and a corneal dystrophy. The On ocular examination, the best visual acuity of the elder brother was 20/100 with both eyes and 20/80 in the younger brother. Their corneas showed numerous superficial and central corneal opacities which were white with irregular and blurred edges. Most opacities were subepithelial; some caused an elevation of the overlying epithelium. There was no breakdown of the corneal epithelium and there was no staining with fluorescein. The intervening cornea showed subepithelial and anterior stromal haziness (Fig  1) . Gonioscopy revealed normal angle structures. Anterior cortical cataracts in a stellate pattern were evident (Fig 2) . The rest of the examination was unremarkable.
Discussion
Dermochondral corneal dystrophy is a rare disorder with only nine cases having been reported in the literature."37 Consanguinity was demonstrated in one case suggesting that transmission may be autosomal recessive. 4 This syndrome consists of a triad of findings which affects the bones of the extremities, the skin, and the cornea. There is an abnormal ossification of cartilage leading to abnormal skeletal development which is limited to the hands and feet. This leads to subluxations and retractions of tendons which gives rise to the deformities. The skin nodules look similar to xanthomas and involve the dorsal surface of joints of fingers, posterior surface of elbows, nose, and external ear (Figs 3,  4) . Although the nodules appear to be xanthomatous they do not stain with lipid stains and probably represent a proliferation of anomalous fibroblasts.'
The ocular syndrome consists of a superficial and central corneal dystrophy with opacities of varying dimensions under the epithelium. The By contrast, our patients had developed skin lesions in infancy, and limb and corneal abnormalities as early as age 3. Moreover, our patients developed anterior corneal stromal opacities, and cataracts which were previously unreported. These observations suggest that the ocular manifestations of this syndrome can be progressive and will probably require therapeutic intervention in the future.
